Search

Your search keyword '"Schizophrenia -- Surveys"' showing total 60 results
Start Over Descriptor "Schizophrenia -- Surveys"
60 results on '"Schizophrenia -- Surveys"'

1. New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY[R] (risperidone) Extended-Release Injectable Suspension at SIRS 2024

Subjects
Teva Pharmaceutical Industries Ltd., Patient compliance -- Surveys, Schizophrenia -- Surveys, Medical personnel -- Surveys, Pharmaceutical industry -- Surveys, Business, Business, international, Austedo (Medication)
Abstract

* PK modeling data provide insights into potential dosing conversions and strategies for switching to UZEDY from a long-acting injectable (LAI) formulation of risperidone microspheres (R064766) * Additional UZEDY data [...]

Published
2024

2. Researchers from Central Institute of Psychiatry Discuss Research in Schizophrenia (The Tamil Version of the Three-Factor Eating Questionnaire-R18V2: Reliability and Factor Structure Among Persons with Schizophrenia)

Subjects
Medical research -- Surveys, Medicine, Experimental -- Surveys, Mental health -- Surveys, Schizophrenia -- Surveys, Disease susceptibility -- Surveys, Health, Psychology and mental health
Abstract

2024 APR 15 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on schizophrenia have been published. According to news reporting out [...]

Published
2024

4. Investigators from Motilal Nehru National Institute of Technology Allahabad Target Artificial Intelligence (Towards Artificial Intelligence In Mental Health: a Comprehensive Survey On the Detection of Schizophrenia)

Subjects
Bipolar disorder -- Surveys, Artificial intelligence -- Surveys, Health surveys -- Surveys, Mental health -- Surveys, Schizophrenia -- Surveys, Technical institutes -- Surveys, Artificial intelligence, Health, Psychology and mental health
Abstract

2022 NOV 28 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on Artificial Intelligence have been published. According to news reporting [...]

Published
2022

7. Development and validation of a self-reported questionnaire on users' opinions about schizophrenia: a participatory research

Author

Magliano, Lorenza, Fiorillo, Andrea, del Vecchio, Heidegret, Malangone, Claudio, de Rosa, Corrado, Bachelet, Carla, Cesari, Giampiero, D'ambrogio, Rosa, Cigala, Francesca Fulgosi, Veltro, Franco, Zanus, Paola, Pioli, Rosaria, and Maj, Mario

Subjects
Schizophrenia -- Surveys, Psychology and mental health, Sociology and social work
Abstract

Background: Although users' involvement in mental health research has repeatedly been acknowledged as having a positive influence on research quality, this rarely happens. Aims: To develop and validate a Questionnaire on Users' Opinions (QOU) about schizophrenia, in close collaboration with 279 persons affected by this disorder. Methods: A preliminary list of items concerning the opinions of users with schizophrenia regarding causes, treatments and psychosocial consequences of the disorder was developed by 38 users with schizophrenia and 40 professionals who attended a workshop. Psychometric properties of the QOU were tested on 241 users with schizophrenia, 149 of whom were randomly assigned to a test-retest study and 92 to a face-validity study. Content and construct validity were explored in the whole sample. Results: The final version of the QOU contains: (1) 24 items on the psychosocial consequences of schizophrenia, grouped into six subscales, whose Cronbach's alpha ranged between 0.55 and 0.74; (2) five multiple choice items on the Italian psychiatric law; (3) 12 open questions; and (4) four yes/no skipping items. Items' reliability, measured by Cohen's kappa coefficient, ranged between 0.55 and 0.92. Conclusion: This questionnaire may be useful to assess patients' beliefs about schizophrenia and to target psychosocial interventions for this mental disorder. Key words: opinions, participatory research, questionnaire, reliability, schizophrenia, users, validity

Published
2009

8. A comparison of African-Caribbean and white European young adults' conceptions of schizophrenia symptoms and the diagnostic label

Author

Stone, L. and Finlay, W.M.L.

Subjects
Schizophrenia -- Surveys, Schizophrenia -- Demographic aspects, Schizophrenia -- Diagnosis, College students -- Surveys, Ethnicity -- Influence, Ethnopsychology -- Research, Psychology and mental health, Sociology and social work
Abstract

Background: Discrepancies in the experiences of different ethnic groups in mental health services exist, such as in the persistently higher rates of schizophrenia diagnosis found among the African-Caribbean population compared to the white European population in the UK. Some hypotheses consider whether this is due to greater stigmatizing attitudes to mental illness in the African-Caribbean community, leading individuals to avoid treatment-seeking and an increased incidence of schizophrenia. This study aimed to investigate recognition and evaluation of schizophrenic symptoms across African-Caribbean and white European individuals. Method: One hundred and twenty eight adult students from London colleges completed a questionnaire assessing stigma beliefs, evaluation of symptoms as mental illness and help-seeking beliefs, in response to symptom vignettes. Results and Discussion: African-Caribbean participants indicated less stigmatizing beliefs towards both the symptoms and diagnostic label of schizophrenia compared to the white European participants. White European participants were more likely to label vignettes as implying 'mental illness' and also more likely to recommend professional health treatment. These results are inconsistent with a hypothesis that on average African-Caribbean people stigmatize schizophrenia more than white European people. While white European participants' beliefs were more likely to follow a western model of mental illness, African-Caribbean participants were more likely to have alternative beliefs. The influence of racial discrimination, mental illness knowledge and societal structures are discussed. Key words: beliefs, schizophrenia, African-Caribbean, White-European, diagnostic label, cross-cultural

Published
2008

9. Ethnicity, goal striving and schizophrenia: a case-control study of three ethnic groups in the United Kingdom

Author

Mallett, Rosemarie, Leff, Julian, Bhugra, Dinesh, Takei, Nori, and Corridan, Bryan

Subjects
Schizophrenia -- Surveys, Ethnic groups -- Surveys, Psychology and mental health, Sociology and social work
Abstract

Background: The need to achieve is common to all societies, and failure to do so may have a highly detrimental psychological impact. For those on the margins of mainstream society, especially migrants or descendants of migrants, the impact of failed or poor achievements may increase their vulnerability to mental illness. Aims: In a prospective study of schizophrenia in three ethnic groups (White, Indian and African-Caribbean) we studied the impact of goal striving and investigated whether the gap between the poor achievement and the high aspirations of members of some minority ethnic groups was potentially a factor contributing to the development of the illness. Methods: The patients and age- and sex-matched controls from their respective communities were asked to rate their perceived current levels of achievement and their past and future expectations in five domains--social standing, housing, education, employment and financial status on a 10-point scale. Results: The control subjects from the three ethnic groups scored similarly in most areas, supporting the validity of inter-ethnic comparisons. The gap between achievement and expectations did not appear to cause high disappointment levels in any group, and in fact only in the domain of housing did the African-Caribbean patients assess their current achievement as being significantly lower than that of their matched controls. Conclusions: Poor housing conditions may be one of the risk factors contributing to the high incidence of schizophrenia in African-Caribbeans.

Published
2004

10. 'A disease like any other'? A decade of change in public reactions to schizophrenia, depression, and alcohol dependence

Author

Pescosolido, Bernice A., Martin, Jack K., Long, J. Scott, Medina, Tait R., Phelan, Jo C., and Link, Bruce G.

Subjects
Neurobiology -- Social aspects, Alcoholism -- Surveys, Schizophrenia -- Surveys, Depression, Mental -- Surveys, Health, Psychology and mental health
Abstract

Objective: Clinicians, advocates, and policy makers have presented mental illnesses as medical diseases in efforts to overcome low service use, poor adherence rates, and stigma. The authors examined the impact of this approach with a 10-year comparison of public endorsement of treatment and prejudice. Method: The authors analyzed responses to vignettes in the mental health modules of the 1996 and 2006 General Social Survey describing individuals meeting DSM-IV criteria for schizophrenia, major depression, and alcohol dependence to explore whether more of the public 1) embraces neurobiological understandings of mental illness; 2) endorses treatment from providers, including psychiatrists; and 3) reports community acceptance or rejection of people with these disorders. Multivariate analyses examined whether acceptance of neurobiological causes increased treatment support and lessened stigma. Results: In 2006, 67% of the public attributed major depression to neurobiological causes, compared with 54% in 1996. High proportions of respondents endorsed treatment, with general increases in the proportion endorsing treatment from doctors and specific increases in the proportions endorsing psychiatrists for treatment of alcohol dependence (from 61% in 1996 to 79% in 2006) and major depression (from 75% in 1996 to 85% in 2006). Social distance and perceived danger associated with people with these disorders did not decrease significantly. Holding a neurobiological conception of these disorders increased the likelihood of support for treatment but was generally unrelated to stigma. Where associated, the effect was to increase, not decrease, community rejection. Conclusions: More of the public embraces a neurobiological understanding of mental illness. This view translates into support for services but not into a decrease in stigma. Reconfiguring stigma reduction strategies may require providers and advocates to shift to an emphasis on competence and inclusion. doi: 10.1176/appi.ajp.2010.09121743

Published
2010

11. Reports from University of Macau Describe Recent Advances in Schizophrenia (Worldwide prevalence of suicidal ideation and suicide plan among people with schizophrenia: a meta-analysis and systematic review of epidemiological surveys)

Subjects
Suicidal behavior -- Surveys, Schizophrenia -- Surveys, Epidemiology -- Surveys, Suicide -- Surveys, Health, Psychology and mental health
Abstract

2021 NOV 15 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Investigators discuss new findings in schizophrenia. According to news reporting originating from the [...]

Published
2021

12. The relationship between severe mental illness and diabetes

Subjects
Type 2 diabetes -- Research, Type 2 diabetes -- Drug therapy, Type 2 diabetes -- Risk factors, Type 2 diabetes -- Surveys, Type 2 diabetes -- Physiological aspects, Type 2 diabetes -- Analysis, Type 2 diabetes -- Reports, Bipolar disorder -- Research, Bipolar disorder -- Drug therapy, Bipolar disorder -- Risk factors, Bipolar disorder -- Surveys, Bipolar disorder -- Physiological aspects, Bipolar disorder -- Analysis, Bipolar disorder -- Reports, Blood sugar monitoring -- Surveys, Blood sugar monitoring -- Physiological aspects, Blood sugar monitoring -- Analysis, Blood sugar monitoring -- Reports, Antipsychotic drugs -- Research, Antipsychotic drugs -- Surveys, Antipsychotic drugs -- Physiological aspects, Antipsychotic drugs -- Analysis, Antipsychotic drugs -- Reports, Glucose tolerance tests -- Surveys, Glucose tolerance tests -- Physiological aspects, Glucose tolerance tests -- Analysis, Glucose tolerance tests -- Reports, Prediabetic state -- Research, Prediabetic state -- Drug therapy, Prediabetic state -- Risk factors, Prediabetic state -- Surveys, Prediabetic state -- Physiological aspects, Prediabetic state -- Analysis, Prediabetic state -- Reports, Blood sugar -- Surveys, Blood sugar -- Physiological aspects, Blood sugar -- Analysis, Blood sugar -- Reports, Medical research -- Surveys, Medical research -- Physiological aspects, Medical research -- Analysis, Medical research -- Reports, Medicine, Experimental -- Surveys, Medicine, Experimental -- Physiological aspects, Medicine, Experimental -- Analysis, Medicine, Experimental -- Reports, Carbohydrate metabolism -- Surveys, Carbohydrate metabolism -- Physiological aspects, Carbohydrate metabolism -- Analysis, Carbohydrate metabolism -- Reports, Obesity -- Research, Obesity -- Drug therapy, Obesity -- Risk factors, Obesity -- Surveys, Obesity -- Physiological aspects, Obesity -- Analysis, Obesity -- Reports, Hyperglycemia -- Research, Hyperglycemia -- Drug therapy, Hyperglycemia -- Risk factors, Hyperglycemia -- Surveys, Hyperglycemia -- Physiological aspects, Hyperglycemia -- Analysis, Hyperglycemia -- Reports, Somatotropin -- Research, Somatotropin -- Surveys, Somatotropin -- Physiological aspects, Somatotropin -- Analysis, Somatotropin -- Reports, Glucose metabolism -- Surveys, Glucose metabolism -- Physiological aspects, Glucose metabolism -- Analysis, Glucose metabolism -- Reports, Dementia -- Research, Dementia -- Drug therapy, Dementia -- Risk factors, Dementia -- Surveys, Dementia -- Physiological aspects, Dementia -- Analysis, Dementia -- Reports, Schizophrenia -- Research, Schizophrenia -- Drug therapy, Schizophrenia -- Risk factors, Schizophrenia -- Surveys, Schizophrenia -- Physiological aspects, Schizophrenia -- Analysis, Schizophrenia -- Reports, Chronic diseases -- Research, Chronic diseases -- Drug therapy, Chronic diseases -- Risk factors, Chronic diseases -- Surveys, Chronic diseases -- Physiological aspects, Chronic diseases -- Analysis, Chronic diseases -- Reports, Insulin resistance -- Research, Insulin resistance -- Surveys, Insulin resistance -- Physiological aspects, Insulin resistance -- Analysis, Insulin resistance -- Reports, Leptin -- Surveys, Leptin -- Physiological aspects, Leptin -- Analysis, Leptin -- Reports, Diabetes therapy -- Surveys, Diabetes therapy -- Physiological aspects, Diabetes therapy -- Analysis, Diabetes therapy -- Reports, Eating disorders -- Research, Eating disorders -- Drug therapy, Eating disorders -- Risk factors, Eating disorders -- Surveys, Eating disorders -- Physiological aspects, Eating disorders -- Analysis, Eating disorders -- Reports, Peptide hormones -- Surveys, Peptide hormones -- Physiological aspects, Peptide hormones -- Analysis, Peptide hormones -- Reports, Corticosteroids -- Research, Corticosteroids -- Surveys, Corticosteroids -- Physiological aspects, Corticosteroids -- Analysis, Corticosteroids -- Reports, Health
Published
2003

13. Data from Louis Mourier Hospital Provide New Insights into Schizophrenia and Related Psychoses (Prevalence and correlates of psychotic-like experiences in the general population)

Subjects
Surveys, Schizophrenia -- Surveys, Mental health -- Surveys, Medical research -- Surveys, Mental disorders, Psychotic disorders, Editors, Diseases
Abstract

2020 MAR 30 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on Mental Health Diseases and Conditions - Schizophrenia and Related [...]

Published
2020

14. New Psychosis Findings from University of East London Outlined (Bad things happen and can drive you crazy: The causal beliefs of 701 people taking antipsychotics)

Subjects
Surveys, Antipsychotic agents -- Surveys, Schizophrenia -- Surveys, Medical research -- Surveys, Mental health -- Surveys, Genetic research, Editors, Diseases
Abstract

2020 MAR 2 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on Mental Health Diseases and Conditions - Psychosis have been [...]

Published
2020

15. Treating comorbid psychiatric and substance use disorders

Author

Minkoff, Kenneth

Subjects
Diseases, Surveys, Substance abuse -- Surveys, Schizophrenia -- Surveys, Comorbidity -- Surveys, Bipolar disorder -- Surveys
Abstract

During the past 10 to 15 years, psychiatrists have increasingly recognized the importance of successfully engaging and treating individuals with comorbid psychiatric and substance use disorders. National epidemiological studies and [...]

Published
2013

16. Rates of Emergency Department Visits Related to Mental Health Disorders Among Adults Aged [greater than or equal to] 18 Years, by Disorder Category--National Hospital Ambulatory Medical Care Survey, United States, 2017-2019

Author

Peters, Zachary J., Davis, Danielle, and Santo, Loredana

Subjects
Health surveys -- Surveys, Hospitals -- Emergency service, Mental health -- Surveys, Schizophrenia -- Surveys, Ambulatory medical care -- Surveys, Health
Abstract

FROM THE NATIONAL FOR HEALTH STATISTICS During 2017-2019, 52.9 ED visits per 1,000 persons were related to a diagnosed MHD in the United States per year. Approximately one half of [...]

Published
2022

17. SCHIZOPHRENIA: DIGITAL TECHNOLOGY DEFIES STIGMA, SUPPORTS RECOVERY

Subjects
Schizophrenia -- Surveys, Mental health -- Surveys, News, opinion and commentary
Abstract

ARLINGTON, VA -- The following information was released by the National Alliance on Mental Illness (NAMI): The National Alliance on Mental Illness (NAMI) has released the results of a survey [...]

Published
2016

18. Schizophrenia: Digital Technology Defies Stigma, Supports Recovery

Subjects
Schizophrenia -- Surveys, Business, News, opinion and commentary
Abstract

ARLINGTON, Va., April 15, 2016 /PRNewswire-USNewswire/ -- The National Alliance on Mental Illness (http://www.nami.org/ ) has released the results of a survey showing that people living with schizophrenia use digital [...]

Published
2016

19. NAMI report: Americans retain conflicted views about schizophrenia

Subjects
Mentally ill -- Health aspects, Schizophrenia -- Risk factors, Schizophrenia -- Care and treatment, Schizophrenia -- Surveys
Abstract

A report released last week by the National Alliance on Mental Illness (NAMI) revealed that while schizophrenia is twice as common as HIV/AIDS and more than 2 million individuals are [...]

Published
2008

20. Researchers' Work from University of Maryland Focuses on Schizophrenia and Related Psychoses (Psychotic Experiences in the Context of Police Victimization: Data From the Survey of Police-Public Encounters)

Subjects
University of Maryland, College Park -- Surveys, Surveys, Schizophrenia -- Surveys, Medical research -- Surveys, Mental health -- Surveys, Epidemiology -- Surveys
Abstract

2017 SEP 29 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Mental Health Diseases and Conditions - Schizophrenia and [...]

Published
2017

21. New Schizophrenia Study Findings Reported from A.A. Hasan and Co-Authors (Self-stigma by people diagnosed with schizophrenia, depression and anxiety: Cross-sectional survey design)

Subjects
Surveys, Depression (Mood disorder) -- Surveys, Schizophrenia -- Surveys, Mental health -- Surveys, Mental health services -- Surveys
Abstract

2017 MAR 13 (NewsRx) -- By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Current study results on Mental Health Diseases and Conditions - Schizophrenia have been [...]

Published
2017

22. Largest Schizophrenia and Schizoaffective Disorder Caregiver Survey Reveals Overwhelming Burden and Inadequate Assistance

Subjects
Schizophrenia -- Surveys, Schizoaffective disorder -- Surveys, Activities of daily living -- Surveys, Business, News, opinion and commentary
Abstract

Findings Highlight Need for Education and More Support for Caregivers TITUSVILLE, N.J., Nov. 13, 2015 /PRNewswire/ -- In recognition of National Family Caregivers Month, Janssen Pharmaceuticals, Inc. today announced results [...]

Published
2015

23. Studies from Ministry of Health Update Current Data on Bipolar Disorders (A Nation-Wide Study on the Percentage of Schizophrenia and Bipolar Disorder Patients Who Earn Minimum Wage or Above)

Subjects
Surveys, Compensation and benefits, Schizophrenia -- Surveys, Medical research -- Surveys, Minimum wage -- Surveys, Bipolar disorder -- Surveys
Abstract

2016 JUN 24 (NewsRx) -- By a News Reporter-Staff News Editor at Health & Medicine Week -- A new study on Mental Health is now available. According to news reporting [...]

Published
2016

24. Schizophrenics battle the disease, the myths

Subjects
Schizophrenia -- Surveys, News, opinion and commentary
Abstract

Byline: Marilyn Elias Schizophrenia carries a lot of stigma, and many Americans believe myths about it that may lead them to steer clear of people with the disease, suggests a [...]

Published
2008

25. Commentary: Watch out for side effects from advertising

Subjects
Eli Lilly and Co. -- Advertising, Pharmaceutical industry -- Surveys, Advertising -- Surveys, Central nervous system agents -- Complications and side effects, Central nervous system agents -- Surveys, Schizophrenia -- Complications and side effects, Schizophrenia -- Surveys, Antipsychotic drugs -- Complications and side effects, Antipsychotic drugs -- Surveys, Business, Business, regional, News, opinion and commentary
Abstract

Warning! Law firm advertising may be bad for your health. At least that's what a survey released on Wednesday by drugmaker Eli Lilly and Co. and the National Council for [...]

Published
2007

26. Nation torn over news vs. security: Poll shows public is 'schizophrenic'

Author

Carr, Rebecca

Subjects
Schizophrenia -- Public opinion, Schizophrenia -- Surveys, General interest, News, opinion and commentary
Abstract

Washington --- Most Americans think news organizations have hurt national security interests by revealing that the government has secretly examined bank records of Americans with suspected ties to terrorists. That [...]

Published
2006

28. PTS SOUGHT FOR SURVEY ON PHYSICAL THERAPY ROLE IN MANAGING SCHIZOPHRENIA

Subjects
Exercise -- Surveys, Therapeutics, Physiological -- Surveys, Schizophrenia -- Surveys, Physical therapy -- Surveys, News, opinion and commentary
Abstract

ALEXANDRIA, Va. -- The following information was released by the American Physical Therapy Association: Researchers from the International Organization of Physical Therapists in Mental Health are seeking input from US [...]

Published
2013

30. First-of-Its-Kind National Online Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia

Subjects
Mental health -- Surveys, Schizophrenia -- Surveys, Health care industry -- Surveys, Business, Science and technology, Health care industry, Surveys
Abstract

The Majority of Respondents Feel Their Overall Health Affects Their Recovery from Schizophrenia SAN DIEGO, Calif., Jan. 29 /PRNewswire-USNewswire/ -- Mental Health America of San Diego today released results of [...]

Published
2008

31. Findings from Research Service in Schizophrenia and Related Psychoses Reported (The Social Cognition Psychometric Evaluation Study: Results of the Expert Survey and RAND Panel)

Subjects
Surveys, Cognition -- Surveys, Schizophrenia -- Surveys, Mental health services -- Surveys, Psychiatric services -- Surveys
Abstract

By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Data detailed on Mental Health Research have been presented. According to news reporting originating in Miami, Florida, by [...]

Published
2014

32. Findings on Schizophrenia Detailed by M. Richards and Co-Authors

Subjects
Surveys, Schizophrenia -- Surveys
Abstract

By a News Reporter-Staff News Editor at Mental Health Weekly Digest -- Investigators discuss new findings in Schizophrenia. According to news reporting from Geneva, Switzerland, by NewsRx journalists, research stated, [...]

Published
2014

33. More than 7.8 million Chinese suffer from schizophrenia

Subjects
Schizophrenia -- Surveys, Pharmaceutical industry -- Surveys
Abstract

BEIJING, Jun 18, 2007 (Xinhua via COMTEX) -- More than 7.8 million Chinese people suffer from schizophrenia and 30 percent of them refuse to take drugs regularly, according to the […]

Published
2007

34. International Caregiver Survey Shows Treatment Disruption Has Serious Consequences for Families Living with Serious Mental Illness; American Caregivers Ask Doctors to Focus on Maintaining Long-Term Wellness

Subjects
Eli Lilly and Co., Pharmaceutical industry -- Surveys, Pharmaceutical industry -- Health aspects, Bipolar disorder -- Care and treatment, Bipolar disorder -- Surveys, Bipolar disorder -- Health aspects, Schizophrenia -- Care and treatment, Schizophrenia -- Surveys, Schizophrenia -- Health aspects, Business, Business, international
Abstract

SPRINGFIELD, Va. -- The disruption of a family member's treatment for mental illness and subsequent worsening of psychiatric symptoms can have harsh financial, physical and emotional consequences for families, according [...]

Published
2006

35. Nonadherent schizophrenia patients

Author

Kirn, Timothy F.

Subjects
Columbia University -- Reports, Schizophrenia -- Surveys, Psychiatrists -- Surveys
Abstract

Patients with schizophrenia who stop taking their medications are more likely to have serious consequences if they do not believe they have a mental illness, a survey of psychiatrists shows. [...]

Published
2006

36. First-line atypicals have similar efficacy in schizophrenia

Author

Sherman, Carl

Subjects
Extrapyramidal disorders -- Causes of, Risperidone -- Health aspects, Clozapine -- Health aspects, Schizophrenia -- Care and treatment, Schizophrenia -- Surveys
Abstract

HARRIMAN, N. Y. -- All atypical antipsychotics have a broader spectrum of efficacy in schizophrenia than conventional neuroleptics, but only clozapine is clearly superior for treatment-resistant patients, Dr. Rajiv Tandon [...]

Published
2004

38. Scientists at University of Sydney target schizophrenia therapy

Subjects
University of Sydney -- Surveys, Surveys, Clozapine -- Surveys, Universities and colleges -- Surveys, Drugs -- Surveys, Schizophrenia -- Surveys, Medical research -- Surveys, Scientists -- Surveys, Medicine, Experimental -- Surveys
Abstract

Data detailed in 'Clozapine and cardiometabolic health in chronic schizophrenia: correlations and consequences in a clinical context' have been presented. According to recent research published in the journal Australasian Psychiatry, [...]

Published
2010

39. Reports from Tilburg University advance knowledge in generics Generics

Subjects
Antipsychotic drugs -- Reports, Antipsychotic drugs -- Surveys, Drugs -- Reports, Drugs -- Surveys, Drugstores -- Reports, Drugstores -- Surveys, Medical research -- Reports, Medical research -- Surveys, Medicine, Experimental -- Reports, Medicine, Experimental -- Surveys, Generic drugs -- Reports, Generic drugs -- Surveys, Pharmacy -- Reports, Pharmacy -- Surveys, Universities and colleges -- Reports, Universities and colleges -- Surveys, Schizophrenia -- Care and treatment, Schizophrenia -- Reports, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

New investigation results, 'Patients' attitudes towards generic substitution of oral atypical antipsychotics: a questionnaire-based survey in a hypothetical pharmacy setting,' are detailed in a study published in CNS Drugs. 'Generic [...]

Published
2009

40. New findings from P.C. Tor and co-authors describe advances in schizophrenia

Subjects
Psychoses -- Research, Psychoses -- Surveys, Schizophrenia -- Research, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

According to recent research published in the journal Annals Academy of Medicine Singapore, 'It is possible to define at risk mental states (ARMS) that predict conversion to schizophrenia in up [...]

Published
2009

41. Research from Children's Hospital, Department of Psychological Medicine provide new insights into psychosis

Subjects
Psychoses -- Research, Psychoses -- Reports, Psychoses -- Surveys, Children's hospitals -- Reports, Children's hospitals -- Surveys, Medical research -- Reports, Medical research -- Surveys, Medicine, Experimental -- Reports, Medicine, Experimental -- Surveys, Schizophrenia -- Research, Schizophrenia -- Reports, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

A report, 'Pervasive developmental disorders and psychosis,' is newly published data in Current Psychiatry Reports. According to recent research from Australia, 'Pervasive developmental disorders (PDDs) and infantile schizophrenia were initially [...]

Published
2009

42. Report summarizes schizophrenia therapy study findings from Research Center

Subjects
Drugs -- Reports, Drugs -- Surveys, Schizophrenia -- Reports, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

A report, 'CNTRICS final task selection: social cognitive and affective neuroscience-based measures,' is newly published data in Schizophrenia Bulletin. 'This article describes the results and recommendations of the third Cognitive [...]

Published
2009

44. Study findings on bipolar disorder are outlined in reports from A.C. Altamura and colleagues

Subjects
Antipsychotic drugs -- Research, Antipsychotic drugs -- Reports, Antipsychotic drugs -- Surveys, Bipolar disorder -- Research, Bipolar disorder -- Reports, Bipolar disorder -- Surveys, Medical research -- Reports, Medical research -- Surveys, Medicine, Experimental -- Reports, Medicine, Experimental -- Surveys, Schizophrenia -- Research, Schizophrenia -- Reports, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

In this recent report, researchers in Germany conducted a study 'To assess European psychiatrists' prescribing behaviour and their perceived need for access to a wide range of atypical antipsychotics for [...]

Published
2008

45. Research from Massachusetts General Hospital reveals new findings on schizophrenia

Subjects
Medical research -- Surveys, Medicine, Experimental -- Surveys, Schizophrenia -- Research, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries, Massachusetts General Hospital -- Surveys
Abstract

According to recent research published in the journal Nature, 'Schizophrenia is a severe mental disorder marked by hallucinations, delusions, cognitive deficits and apathy, with a heritability estimated at 73 - [...]

Published
2008

46. Investigators at Yale University, Department of Psychiatry target schizophrenia

Subjects
Universities and colleges -- Reports, Universities and colleges -- Surveys, Medical research -- Reports, Medical research -- Surveys, Medicine, Experimental -- Reports, Medicine, Experimental -- Surveys, Schizophrenia -- Reports, Schizophrenia -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries
Abstract

Current study results from the report, 'Experiential features used by patients with schizophrenia to differentiate 'voices' from ordinary verbal thought,' have been published. 'Determining how patients distinguish auditory verbal hallucinations [...]

Published
2008

47. New schizophrenia study findings reported from Washington University

Subjects
Drugs -- Research, Drugs -- Reports, Drugs -- Surveys, Therapeutics -- Reports, Therapeutics -- Surveys, Universities and colleges -- Reports, Universities and colleges -- Surveys, Neurosciences -- Reports, Neurosciences -- Surveys, Schizophrenia -- Research, Schizophrenia -- Reports, Schizophrenia -- Surveys, Homeopathy -- Materia medica and therapeutics, Homeopathy -- Reports, Homeopathy -- Surveys, Biotechnology industry, Pharmaceuticals and cosmetics industries, Washington University -- Reports, Washington University -- Surveys
Abstract

'This overview describes the goals and objectives of the second conference conducted as part of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia (CNTRICS) initiative. This second conference [...]

Published
2008

48. Tier Status in Private Insurance Plans for Other Antipsychotic Drugs Will Remain Largely Unchanged Following the Patent Expiry of Janssen's Risperdal

Subjects
Patent/copyright issue, Marketing research, Pharmaceutical industry -- Market research, Pharmaceutical industry -- Intellectual property, Pharmaceutical industry -- Reports, Pharmaceutical industry -- Surveys, Drugs -- Market research, Drugs -- Reports, Drugs -- Surveys, Antipsychotic drugs -- Reports, Antipsychotic drugs -- Surveys, Patents -- Reports, Patents -- Surveys, Schizophrenia -- Reports, Schizophrenia -- Surveys
Abstract

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that when Janssen's Risperdal (risperidone) loses market exclusivity later this year in the [...]

Published
2008

49. Researchers from University of Iowa report recent findings in schizophrenia

Subjects
Universities and colleges -- Reports, Universities and colleges -- Surveys, Psychiatric services -- Reports, Psychiatric services -- Surveys, Schizophrenia -- Research, Schizophrenia -- Reports, Schizophrenia -- Surveys
Abstract

According to recent research from the United States, "This study examined the helpfulness of coping strategies and the relative importance of mental health services in coping with schizophrenia from the [...]

Published
2008

50. Research on schizophrenia published by V.L. Lyus et al

Subjects
Medical genetics -- Reports, Medical genetics -- Surveys, Schizophrenia -- Reports, Schizophrenia -- Surveys
Abstract

"Genetic counseling is a health service, which has been indicated for individuals with psychiatric conditions in their families (see also Schizophrenia). However, little is known about the awareness and/or experiences [...]

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results